“Molecular Interception of Disease” is based on a simple premise: molecular changes associated with pathogenesis may occur before the clinical onset of disease. Thus, detection of such “molecular symptoms” could prompt therapeutic intervention that will stop the disease and
prevent clinical manifestations. This symposium will also explore the use of “deep“ molecular phenotyping technologies for the investigation of temporal changes in transcriptome, proteome, metabolome or microbiome profiles. The application of this concept to preclinical “molecular interception” of therapeutic responses or adverse events will also be discussed.
Benefits to Attend
Participants will be able to:
- Attend presentations and discussions by world-renowned researchers, scientists, physicians, and academics from across the globe. It will be an engaging and interactive platform to network and discuss collaborative partnerships as well as share knowledge and ideas related to the latest developments and advancements in approaches to molecular interception of disease
- Learn about emerging molecular and cellular profiling technologies employed for health and disease monitoring applications
- Learn about methods used for the analysis of time series data
- Learn from poster and oral abstract presenters selected by the organizing committee to showcase research projects that are relevant to these topics.
Submission of abstracts relevant to the topics covered during the symposium is encouraged. Abstracts will be selected for an oral or poster presentation. Selected oral presenters may be eligible to receive a travel award.
Please include title, a list of authors and affiliations, and indicate who will be the presenter. Word limit for the abstract is 200.
Abstract submissions to Mrs. Afshan Khan email@example.com
Abstract submission closes on October 1st 2016.
- Damien Chaussabel (Committee Chair), Department of System Biology, Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar
- Ena Wang, Research Chief – Translational Medicine, Sidra Medical and Research Center, Doha, Qatar
- Davide Bedognetti, Tumor Biology, Immunology and Therapy Section, Sidra Medical and Research Center, Doha, Qatar
- Sara Al Zaidan, Clinical Nutrition and Research Coordinator, Sidra Medical and Research Center, Doha, Qatar
- Afshan Khan, Executive Assistant to Dr. Ena Wang Research Chief, Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar